Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

WuXi Invests In Genomics Data Firm

by Michael McCoy
April 27, 2015 | A version of this story appeared in Volume 93, Issue 17

WuXi PharmaTech, a Shanghai-based pharmaceutical services firm, has invested $15 million in DNAnexus, which calls itself the leader in cloud-based genome data management. Along with the investment, genome-sequencing services offered by WuXi’s NextCode business will become available via DNAnexus’s cloud computing service. WuXi acquired NextCode earlier this year. DNAnexus CEO Richard Daly notes that China is home to 20% of the world’s DNA-sequencing capacity.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.